H19 sense and antisense transgenes modify insulin-like growth factor-II mRNA levels

European Journal of Biochemistry

Volumn 267, Issue 13, 2000, Pages 4020-4027

  Wilkin, Françoise ^a   Paquette, Jean ^a   Ledru, Elisabeth ^a   Mamelin, Catherine ^b   Pollak, Michael ^b   Deal, Cheri L ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Gene regulation; H19; Insulin like growth factor II; Tumor suppressor genes

Indexed keywords

COMPLEMENTARY RNA; MESSENGER RNA; SOMATOMEDIN B;

ARTICLE; CYTOMEGALOVIRUS INFECTION; DNA SEQUENCE; GENE ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; NORTHERN BLOTTING; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; TUMOR SUPPRESSOR GENE; ERRATUM; ERROR;

CYTOMEGALOVIRUS;

EID: 0033918066     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01438.x     Document Type: Article

References (54)

1. 1. Stewart, C.E.H. & Rotwein, P. (1996) Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol. Rev. 76, 1005-1026.
2. 2. Zhang, L., Kashandi, F., Zhan, Q., Zhan, S., Brady, J.N., Fornace, A.J., Seth, P. & Helman, L.J. (1996) Regulation of insulin-like growth factor II P3 promoter by p53: a potential mechanism for tumorogenesis. Cancer Res. 56, 1367-1373.
3. 3. Drummond, I.A., Madden, S.L., Rohwer-Nutter, P., Bell, G.I., Sukhatme, V.P. & Rauscher, F.J. III (1992) Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 257, 674-678.
4. 4. Sussenbach, J.S., Rodenburg, R.J.T., Scheper, W. & Holthuizen, P. (1994) Transcriptional and post-transcriptional regulation of the human IGF-II gene expression. In Current Directions in Insulin-like Growth Factor Research (LeRoith, D. & Raizada, M.K., eds), pp. 63-71. Plenum Press, New York, USA.
5. 5. Paquette, J., Giannoukakis, N., Vafiadis, P., Polychronakos, C. & Deal, C. (1998) The INS 5′ variable number of tandem repeats is associated with IGF2 expression in human. J. Biol. Chem. 273, 14158-14164.
6. 6. Giannoukakis, N., Deal, C., Paquette, J., Goodyer, C. & Polychronakos, C. (1993) Parental imprinting of the human IGF2 gene. Nat. Genet. 4, 98-101.
7. 7. Gicquel, C., Raffin-Sanson, M.L., Gaston, V., Bertagna, X., Plouin, P.F., Schlumberger, M., Louvel, A., Luton, J.P. & Le Bouc, Y. (1997) Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J. Clin. Endocrinol. Metab. 82, 2559-2565.
8. 8. Lalande, M. (1997) Parental imprinting and human disease. Annu. Rev. Genet. 30, 173-195.
9. 9. Zemel, S., Bartolomei, M.S. & Tilghman, S.M. (1992) Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2. Nat. Genet. 2, 61-65.
10. 10. Brannan, C.I., Dees, E.C., Ingram, R.S. & Tilghman, S.M. (1990) The product of the H19 gene may function as an RNA. Mol. Cell. Biol. 10, 28-36.
11. 11. Joubel, A., Curgy, J.-j., Pelczar, H., Begue, A., Lagrou, C., Stehelin, D. & Coll, J. (1996) The 5′ part of the human H19 RNA contains cis-acting elements hampering its translatability. Cell. Mol. Biol. 42, 1159-1172.
12. 12. Hurst, L.D. & Smith, N.G. (1999) Molecular evolutionary evidence that H19 mRNA is functional. Trends Genet. 15, 134-135.
13. 13. Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E. & Tycko, B. (1993) Tumour-suppressor activity of H19 RNA. Nature 365, 764-767.
14. 14. Lustig-Yariv, O., Schulze, E., Komitowski, D., Erdmann, V., Schneider, T., de groot, N. & Hochberg, A. (1997) The expression of the imprinted genes H19 and IGF-2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene? Oncogene 15, 169-177.
15. 15. Cui, H., Hedborg, F., He, L., Nordenskjöld, A., Sandstedt, B., Pfeiferohlsson, S. & Ohlsson, R. (1997) Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorogenesis. Cancer Res. 57, 4469-4473.
16. 16. Zhang, Y. & Tycko, B. (1992) Monoallelic expression of the human H19 gene. Nat. Genet. 1, 40-44.
17. 17. Ohlsson, R., Hedborg, F., Holmgren, L., Walsh, C. & Ekström, T.J. (1994) Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with lack of H19 expression. Development 120, 361-368.
18. 18. Li, E., Bester, T.H. & Jaenisch, R. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926.
19. 19. Leighton, P.A., Ingram, R.S., Eggenschwiler, J., Efstratiadis, A. & Tilghman, S.M. (1995) Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375, 34-39.
20. 20. Ripoche, M.-a., Kress, C., Poirier, F. & Dandolo, L. (1997) Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. Genes Dev. 11, 1596-1604.
21. 21. Moulton, T., Crenshaw, T., Hao, Y., Moosikasuwan, J., Lin, N.A., Dembizer, F., Hensle, T., Weiss, L., McMorrow, L., Loew, T., Kraus, W., Gerald, W. & Tycko, B. (1994) Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat. Genet. 7, 440-447.
22. 22. Liu, J., Kahri, A.I., Heikkila, P., Ilvesmaki, V. & Voutilainen, R. (1995) H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells. J. Clin. Endocrinol. Metab. 80, 492-496.
23. 23. Giannoukakis, N., Deal, C., Paquette, J., Kukuvitis, A. & Polychronakos, C. (1996) Polymorphic functional imprinting of the human IGF2 gene among individuals, in blood cells, is associated with H19 expression. Biochem. Biophys. Res. Commun. 220, 1014-1019.
24. 24. Webber, A.L. & Tilghman, S.M. (1998) The absence of enhancer competition between Igf2 and H19 following transfer into differentiated cells. Mol. Cell. Biol. 18, 1903-1910.
25. 25. Jones, B.K., Levorse, J.M. & Tilghman, S.M. (1998) Igf2 imprinting does not require its own DNA methylation or H19 RNA. Genes Dev. 12, 2200-2207.
26. 26. Schmidt, J.V., Levorse, J.M. & Tilghman, S.M. (1999) Enhancer competition between H19 and Igf2 does not mediate their imprinting. Proc. Natl Acad. Sci. USA 96, 9733-9738.
27. 27. Li, Y.-M., Franklin, G., Cui, H.-M., Svensson, K., He, X.-B., Adam, G., Ohlsson, R. & Pfeifer, S. (1998) The H19 transcript is associated with polysomes and may regulate IGF2 expression in trans. J. Biol. Chem. 273, 28247-28252.
28. 28. Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-169.
29. 29. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, USA.
30. 30. Rainier, S., Johnson, L.A., Dobry, C.J., Ping, A.J., Grundy, P.E. & Feinberg, A.P. (1993) Relaxation of imprinted genes in human cancer. Nature 362, 747-749.
31. 31. Förster, E. (1994) An improved general method to generate internal standards for competitive PCR. Biotechniques 16, 18-20.
32. 32. Tang, J., Lagacé, G. & Collu, R. (1996) Simple method for constructing internal standards for competitive PCR. Biotechniques 21, 378-380.
33. 33. Rodenburg, R.J.T., Teertstra, W., Holthuizen, P.E. & Sussenbach, J.S. (1995) Postnatal liver-specific expression of human insulin-like growth factor-II is highly stimulated by the transcriptional activators liver-enriched activating protein and CCAAT/enhancer binding protein. Mol. Endocrinol. 9, 424-434.
34. 34. Lin, S.B., Hsieh, S.H., Hsu, H.L., Lai, M.Y., Kan, L.S. & Au, L.C. (1997) Antisense oligonucleotides of IGF-II selectively inhibit growth of human hepatoma cells overproducing IGF-II. J. Biochem. 122, 717-722.
35. 35. Davies, S.M. (1993) Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma. Cancer Res. 53, 4781-4783.
36. 36. Junien, C. (1992) Beckwith-Wiedemann syndrome tumorogenesis and imprinting. Curr. Opin. Genet. Dev. 2, 431-438.
37. 37. Sun, F.-l., Dean, W.L., Kelsey, G., Allen, N.D. & Reik, W. (1997) Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 389, 809-815.
38. 38. Koi, M., Johnson, L.A., Kalikin, L.M., Little, P.F., Nakamura, Y. & Feinberg, A.P. (1993) Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science 260, 361-364.
39. 39. Thorvaldsen, J.L., Duran, K.L. & Bartolomei, M.S. (1998) Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev. 12, 3693-3702.
40. 40. Khosla, S., Aitchison, A., Gregory, R., Allen, N.D. & Feil, R. (1999) Parental allele-specific chromatin configuration in a boundary-imprinting-control element upstream of the mouse H19 gene. Mol. Cell. Biol. 19, 2556-2566.
41. 41. Jouvenot, Y., Poirier, F., Jami, J. & Paldi, A. (1999) Biallelic transcription of Igf2 and H19 in individual cells suggests a posttranscriptional contribution to genomic imprinting. Curr. Biol. 9, 1199-1202.
42. 42. Grant, S.R. (1999) Dissecting the mechanisms of posttranscriptional gene silencing: divide and conquer. Cell 96, 303-306.
43. 43. De Moor, C.H., Jansen, M., Sussenbach, J.S. & Van den brande, J.L. (1994) Differential polysomal localization of human insulin-like growth factor-2 mRNA in cell lines and foetal liver. Eur. J. Biochem. 222, 1017-1024.
44. 44. Nielsen, F.C., Ostergaard, L., Nielsen, J. & Christiansen, J. (1995) Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature 377, 358-362.
45. 45. Kiess, W., Paquette, J., Koepf, G., Wolf, E. & Deal, C. (1999) Proinsulin-like growth factor-II overexpression does not alter monoallelic H19 gene expression in transfected human embryonic kidney fibroblasts. Biochem. Biophys. Res. Commun. 255, 226-230.
46. 46. Brown, C.J., Hendrich, B.D., Rupert, J.L., Lafrenière, R.G., Xing, Y., Lawrence, J. & Willard, H.F. (1992) The human XIST gene: analysis of a 17-kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 71, 527-542.
47. 47. Penny, G.D., Kay, G.F., Sheardown, S.A., Rastan, S. & Brockdorff, N. (1996) Requirement for Xist in X chromosome inactivation. Nature 379, 131-137.
48. 48. Pfeifer, K. & Tilghman, S.M. (1994) Allele-specific gene expression in mammals: the curious case of the imprinted RNAs. Genes Dev. 8, 1867-1874.
49. 49. Wevrick, R., Kerns, J.A. & Francke, U. (1994) Identification of a novel paternally expressed gene in the Prader-Willi syndrome region. Hum. Mol. Genet. 3, 1877-1882.
50. 50. Dittrich, B., Buiting, K., Korn, B., Rickard, S., Buxton, J., Saitoh, S., Nicholls, R., Poustka, A., Winterpacht, A., Zabel, B. & Horsthemke, B. (1996) Imprint switching on human chromosome 15 involves alternative transcripts of the SNRPN gene. Nat. Genet. 14, 163-170.
51. 51. Lee, M.P., Hu, R.-J., Johnson, L.A. & Feinberg, A.P. (1997) Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat. Genet. 15, 181-185.
52. 52. Wutz, A., Smrzka, O.W., Schweifer, N., Schellanders, K., Wagner, E.F. & Barlow, D.P. (1997) Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 389, 745-749.
53. 53. Rougeulle, C., Cardoso, C., Fontés, M., Colleaux, L. & Lalande, M. (1998) An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript. Nat. Genet. 19, 15-16.
54. 54. Heard, E., Lovell-Badge, R. & Avner, P. (1999) Anti-Xistentialism. Nat. Genet. 21, 343-344.55.